Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
Abroad (travel likely)RecruitingPHASE3
Conditions
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Demyelinating Autoimmune Diseases, CNS · Autoimmune Diseases of the Nervous System · Nervous System Diseases · Demyelinating Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Amsterdam UMC, location VUmc, Amsterdam, Netherlands
Contact: Study coordinator (B. van Oosten, Dr.)Contact: Study coordinator (E. Strijbis, Dr.)
Study leads
Bob van Oosten, Dr
Principal Investigator
Amsterdam UMC, location VUmc